Summary
Background
People with melanoma want and need effective interventions for living with fear of cancer recurrence (FCR).
Objectives
This study reports the 12âmonth outcomes of a brief, psychological intervention designed to reduce FCR in people at high risk of developing another primary melanoma compared with usual care.
Methods
In this twoâarm randomized controlled trial, adults previously diagnosed with stage 0, I or II melanoma were randomly allocated to the intervention (n = 80) or control (usual care) arm (n = 84). The trial was registered with the Australian and New Zealand Clinical Trials Registry on 19 March 2013 (registration: ACTRN12613000304730). The intervention comprised a 76âpage psychoeducational resource and three individually tailored, telephoneâbased sessions with a psychologist, scheduled at specific time points around participantsâ dermatological appointments. The primary outcome was the level of selfâreported fear of new or recurrent melanoma assessed at 12 months postintervention using the severity subscale of the Fear of Cancer Recurrence Inventory.
Results
Compared with the control arm, the intervention group reported significantly lower FCR at 12 months postintervention; the betweenâgroup mean difference was â1·41 for FCR severity [95% confidence interval (CI) â2·6 to â0·2; P = 0·02] and â1·32 for FCR triggers (95% CI â2·6 to â0·02; P = 0·04). The odds ratio for FCR severity scores â„13 (54% intervention, 63% control) was 0·59 (95% CI 0·30â1·14, P = 0·12). There were no differences between groups in secondary outcomes, such as anxiety, depression or healthârelated quality of life.
Conclusions
The previously reported 6âmonth benefits of this brief, patientâcentred psychological intervention in reducing FCR were found to continue 12 months postintervention, with no known adverse effects, supporting implementation as part of routine melanoma care.